Literature DB >> 17177143

Severe hypernatraemia due to nephrogenic diabetes insipidus - a life-threatening side effect of chronic lithium therapy.

L Sze1, B Ulrich, M Brändle.   

Abstract

Renal toxicity of long-term lithium therapy is a common problem. Nephrogenic diabetes insipidus is the most frequently encountered complication, but often remains unrecognised because of the rather benign symptoms. We present a patient with long-term lithium therapy who developed life-threatening hypernatraemia due to insufficient oral fluid intake after elective spinal surgery. Careful daily substitution of up to 25 l of hypotonic fluids led to full recovery within 9 days. Nephrogenic diabetes insipidus should always be considered in lithium-treated patients undergoing elective surgery in order to avoid severe hypernatraemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177143     DOI: 10.1055/s-2006-924124

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

1.  Prolonged hypernatremia triggered by hyperglycemic hyperosmolar state with coma: A case report.

Authors:  Darlene Vigil; Kavitha Ganta; Yijuan Sun; Richard I Dorin; Antonios H Tzamaloukas; Karen S Servilla
Journal:  World J Nephrol       Date:  2015-05-06

Review 2.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

3.  Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus.

Authors:  Nihat Aksakal; Candaş Erçetin; Beyza Özçınar; Ferihan Aral; Yeşim Erbil
Journal:  Ulus Cerrahi Derg       Date:  2015-09-01

4.  Severe hypernatremia and hyperchloremia in an elderly patient with IgG-kappa-type multiple myeloma.

Authors:  Shinsaku Imashuku; Naoko Kudo; Kagekatsu Kubo
Journal:  J Blood Med       Date:  2013-05-14

5.  Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy.

Authors:  Kyung Yoon Chang; In-Hee Lee; Gi Jun Kim; Kangwon Cho; Hoon Suk Park; Hyung Wook Kim
Journal:  BMC Nephrol       Date:  2014-04-04       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.